LUPIN

has received USFDA approval for Lenalidomide capsules, a $7.5 billion annual sales drug, used to treat Multiple Myeloma in combination with dexamethasone and as maintenance following stem cell transplantation. The capsules will be manufactured at Lupin's Pithampur facility in various strengths and traded in the US market.